Related by context. All words. (Click for frequent words.) 81 Receptor Antagonist 78 Receptor Agonist 75 Cannabinoid 75 Tyrosine Kinase Inhibitor 75 Tumor Necrosis Factor 74 Epidermal Growth Factor Receptor 74 Aurora Kinase 73 Prolongs Survival 73 Neuroprotective 73 Analogs 73 Interferon Beta 73 Cyclooxygenase 2 73 Immunomodulatory 72 Recombinant Human 72 Aliskiren 72 Kinase Inhibitor 72 Monotherapy 72 HDAC Inhibitor 72 Phase 2b Trial 71 Well Tolerated 71 Inhibitors 71 Randomized Phase 71 Bortezomib 71 Factor Receptor 71 Transdermal Delivery 71 Phase 2b Study 71 Oral Fingolimod 71 Double Blind Randomized 71 Angiotensin Converting Enzyme 71 Antiviral Activity 71 Novel Mechanism 71 Anti Tumor 71 Pharmacodynamics 71 receptor agonists 71 Orally Active 71 Potent Inhibitor 71 Incretin 71 Diabetic Neuropathy 71 Cytochrome P# 71 selective modulator 71 Reductase 70 Nucleoside 70 Dendritic Cells 70 Phase 2a Clinical Trial 70 Drug Candidate 70 Monoclonal Antibody 70 Protease Inhibitors 70 Protease Inhibitor 70 selective antagonist 70 Phase IIb Trial 70 Replacement Therapy 70 Angiogenic 70 Dasatinib 70 Single Dose 70 Chemokine Receptor 70 Methylnaltrexone 70 Progenitor Cells 70 Pharmacokinetic Study 70 Phase 2b Clinical Trial 70 Receptor Agonists 70 sodium glucose cotransporter 70 Proteasome 70 Androgen Receptor 70 5 hydroxytryptamine 70 Antitumor Activity 70 Estrogen Receptor 70 Mimetics 70 Low Dose 70 Benign Prostatic Hyperplasia 70 Present Preclinical Data 70 Sapacitabine 70 Antiangiogenic 70 Smooth Muscle 70 Inhibitor 70 Placebo Controlled Trial 70 Pooled Analysis 69 Granulocyte Colony Stimulating Factor 69 Diabetic Nephropathy 69 Attenuates 69 Tiotropium 69 Clinical Trial Results 69 Fibrinogen 69 Peginterferon Alfa 2a 69 Decitabine 69 Combination Treatment 69 Initiate Phase 69 Signaling Pathway 69 Adjuvant Chemotherapy 69 Denufosol 69 Thrombotic 69 Pegylated 69 Dehydrogenase 69 Cytotoxic 69 Neuroprotective Effects 69 Bosentan 69 Bosutinib 69 Novel Antibiotic 69 Skeletal Muscle 69 Tumor Targeting 69 cyclin dependent kinase inhibitor 69 Modulates 69 Capecitabine 69 Peginterferon 69 5 HT6 receptor 69 Mouse Model 69 Interferon Alfa 69 JAK Inhibitor 69 Meets Primary Endpoint 69 Transcription Factor 69 Androgen 69 Pramlintide 69 Angiotensin II 69 Angiotensin 69 Protein Kinase 69 Atypical Antipsychotic 69 Kinase Inhibitors 69 Statistically Significant 69 Novel Oral 68 Successfully Completes Phase 68 Previously Treated 68 Inhibits 68 Tubulin 68 Systemic Delivery 68 Demonstrates Potent 68 Antifungal 68 ADP receptor antagonist 68 Muscarinic 68 IND Application 68 Interferon Gamma 68 Bevacizumab 68 Pulmonary Arterial Hypertension 68 Phase 1b Clinical Trial 68 Controlled Trial 68 Oral Formulation 68 Romiplostim 68 Cell Adhesion 68 Hsp# Inhibitor 68 selective phosphodiesterase 68 Controlled Study 68 Prodrug 68 Thiazolidinediones 68 Anti Inflammatory 68 Investigational Drug 68 See CLINICAL PHARMACOLOGY 68 Dose Escalation 68 fosbretabulin 68 Cyclooxygenase 68 Macrophage 68 Phase IIa Clinical Trial 68 Hypertensive Patients 68 Febuxostat 68 Anti TNF 68 Disease Modifying 68 Plus Ribavirin 68 Treating Chronic 68 P2Y 68 Initiates Clinical 68 liposomal formulation 68 Antitumor 68 Hepatitis C Genotype 68 Fungal Infections 68 Complicated Skin 68 Disease Progression 68 5HT 68 PEGylated Fab fragment 68 Allogeneic 68 ACE Inhibitors 68 Enzyme Replacement Therapy 68 endothelin receptor 68 Double Blind Placebo 68 Blinatumomab 68 Long Term Efficacy 68 Unfractionated Heparin 68 Therapeutic Potential 68 Phase 2a Trial 68 Antithrombin 68 5alpha reductase 68 Phosphodiesterase 68 Potent Anti 67 octreotide acetate 67 Leukotriene 67 receptor antagonists 67 Prophylactic Treatment 67 Itraconazole 67 Lenalidomide 67 Preclinical Data 67 Adjuvant Therapy 67 Study Evaluating 67 receptor blocker 67 Demonstrates Efficacy 67 Lung Cancer Drug 67 IL6 67 CYP#A# CYP#D# 67 Anti Tumor Activity 67 Aldosterone 67 Lubiprostone 67 Vidaza azacitidine 67 Presents Preclinical Data 67 Orally administered 67 Treatment Naïve 67 Hormone Refractory Prostate Cancer 67 Enzastaurin 67 Liposomal 67 Combination Therapy 67 Placebo Controlled Study 67 Fulvestrant 67 Lacosamide 67 Cinacalcet 67 TNF Alpha 67 Hypercholesterolemia 67 selective inhibition 67 GW# [003] 67 thrombin receptor 67 Janus kinase 67 receptor modulators 67 Inhibitory 67 Mg Usa 67 Tumor Suppressor 67 Pegylated Liposomal Doxorubicin 67 GLP1 67 cyclooxygenase 67 Randomized Double blind 67 Tezampanel 67 Induces 67 Metastatic Melanoma 67 Antagonists 67 Agonist 67 Safinamide 67 Improve Survival 67 Parathyroid Hormone 67 Polymerase Inhibitor 67 CYP #A# 67 Non Responders 67 Investigational Agent 67 Chemoradiation 67 Epoetin 67 Akt activation 67 Malignant Glioma 67 Epratuzumab 67 Dose Response 67 JAK2 Inhibitor 67 nucleoside analog 67 Secretion 67 cis retinoic acid 67 Aortic Stenosis 67 Ranolazine 67 Degarelix 67 Catenin 67 Insulin Glargine 67 prostanoid 67 Novel Therapeutic 67 Improves Outcomes 67 Cholesterol Lowering Drug 67 GHRH 67 Initiates Phase 67 II Clinical Trial 67 HCV Genotype 67 receptor partial agonist 67 Chemotherapy Induced 67 Antigen Specific 67 Mg Uk 67 insulin sensitizers 67 Allergic Rhinitis 67 Montelukast 67 antisense inhibitor 67 Phase Ib Clinical Trial 67 Synthase 67 Completes Patient Enrollment 67 Extended Release 66 Avanafil 66 Small Molecule Inhibitors 66 Vitro Activity 66 extracellular signal 66 Intravesical 66 Investigational Compound 66 opioid receptor antagonist 66 Adenosine 66 Glucocorticoid 66 Fondaparinux 66 Acute Ischemic Stroke 66 Fluorouracil 66 plasmid encoding 66 Confirmatory Phase 66 Unresectable 66 Dose Ranging Study 66 2A receptor agonist 66 Gout Drug 66 PPARgamma 66 Pemetrexed 66 Signaling Pathways 66 Ziprasidone 66 Dose Escalation Study 66 Uric Acid 66 Pivotal Phase 66 topoisomerase II inhibitor 66 oral prodrug 66 Adjunctive Therapy 66 Talabostat 66 Protein Kinase C 66 VEGF inhibitors 66 Prostaglandin 66 gonadotropin releasing hormone GnRH 66 immunostimulatory 66 prucalopride 66 uricase 66 Cilostazol 66 Carbamazepine 66 soluble tumor necrosis 66 N methyl 66 interleukin IL -# 66 Phase IIb Clinical Trial 66 Transgenic Mice 66 Estradiol 66 beta adrenergic 66 Phosphorylation 66 MAGE A3 ASCI 66 Phase III Clinical Trial 66 Taxane 66 Breast Cancer Cells 66 mineralocorticoid receptor 66 Pathway Inhibitor 66 Receives Orphan Drug Designation 66 PEG IFN 66 Pharmacologic 66 PKC# 66 cortisol synthesis 66 Adjuvant Treatment 66 Myelofibrosis 66 Knee Osteoarthritis 66 TLK# 66 Histone 66 Voreloxin 66 Effectively Treats 66 Metastatic Prostate Cancer 66 Appears Safe 66 CDK inhibitor 66 Immune Responses 66 Novel Inhibitor 66 Beta Blocker 66 EGFR HER2 66 mediated apoptosis 66 Bicalutamide 66 receptor tyrosine kinase inhibitor 66 Is Well Tolerated 66 protein tyrosine phosphatase 1B 66 Late Breaker 66 Diabetic Foot Ulcer 66 Overactive Bladder 66 Advanced Renal Cell 66 Fibrates 66 Lamotrigine 66 inverse agonist 66 ISTODAX 66 Etanercept 66 Prodrugs 66 Oral Spray 66 Traficet EN 66 Diuretic 66 Squalamine 66 small molecule Hedgehog 66 Epithelial 66 Anticoagulant 66 Inhaled Corticosteroids 66 reuptake inhibitor 66 Trandolapril 66 VAPRISOL 66 Shows Promise Against 66 JAK2 enzyme 66 inhibiting COX 66 Renal Cell Carcinoma 66 alefacept 66 Intracranial Aneurysms 66 Transcriptional 66 Antitumor activity 66 Preclinical Models 66 beta 1a 66 Retinoic Acid 66 Aflibercept 66 Immunosuppression 66 Intranasal 66 Hepatotoxicity 66 Patients Receiving 66 Pralatrexate 66 reversible inhibitor 66 phosphatidylinositol 3 66 Efficacious 66 Tumor Growth 66 Dapagliflozin 66 Clinical Outcome 66 Tesamorelin 66 Relapsing Multiple Sclerosis 66 SGLT 66 Anthracycline 66 Pharmacological 66 Anticholinergic 66 SGLT2 66 Demonstrated Significant 66 Adefovir 66 Soft Tissue Sarcoma 66 Erlotinib 66 Improves Survival 66 Nilotinib 66 selective adenosine 65 Inactivation 65 XYOTAX TM 65 interferon IFN 65 cyclooxygenase COX 65 Medullary Thyroid Cancer 65 Somatostatin 65 Intracellular 65 Trastuzumab 65 Tasimelteon 65 mertansine 65 Myelodysplastic Syndromes 65 MEK1 65 peripherally acting 65 Analgesic 65 Golimumab 65 IFN α 65 Infected Patients 65 Cytotoxicity 65 Neoadjuvant Chemotherapy 65 investigational humanized monoclonal antibody 65 Diffuse Large B 65 arginine vasopressin AVP 65 Therapeutic Targets 65 Diabetic Neuropathic Pain 65 Xanafide 65 Antisense 65 Mycophenolate Mofetil 65 Clinical Trial Evaluating 65 Teriparatide 65 selective serotonin 2C receptor 65 Sulfonylurea 65 Corticosteroid 65 Glatiramer Acetate 65 glycogen synthase kinase 65 Maribavir 65 Pazopanib 65 neurokinin 65 highly selective inhibitor 65 receptor agonist 65 Files IND 65 peripherally restricted 65 Protease 65 Aptamer 65 Histone Deacetylase 65 Upregulation 65 Neural Stem Cells 65 muscarinic 65 Blood Pressure Drug 65 Protein Synthesis 65 selective A2A adenosine receptor 65 Advanced Melanoma 65 Pivotal Phase III 65 histone deacetylase inhibitor 65 Cutaneous T 65 Interferon gamma 65 chemokine receptor 65 HDACi 65 Randomized Double Blind Placebo 65 Formoterol 65 Novel Small Molecule 65 MULTAQ 65 peptide CGRP 65 Treatment Reduces 65 Inflammatory Markers 65 Fibroblast Growth Factor 65 Homeostasis 65 DNA intercalator 65 Factor VIIa 65 Mucosal 65 NMDA antagonist 65 proteasome inhibitor 65 Fludarabine 65 Epothilone 65 Fewer Side Effects 65 humanized monoclonal 65 Randomized Placebo Controlled Trial 65 Oncolytic 65 Pafuramidine 65 AT1R 65 Cytotoxic T 65 Lung Cancer Trial 65 5 Fluorouracil 65 Diabetic Patients 65 polycythemia vera PV 65 5 HT2A 65 Mutational 65 BANZEL 65 Anticoagulants 65 Patients Treated With 65 SPRYCEL ® 65 Natalizumab 65 Secretory 65 Insulin Resistance 65 Antiviral Therapy 65 coadministration 65 HMG CoA reductase inhibitors 65 Pharmacokinetics PK 65 Achieves Primary Endpoint 65 Metabolites 65 Cardiotoxicity 65 EZN 65 Risperidone 65 laropiprant 65 ritonavir boosted 65 IGF1R 65 Small Molecule 65 Myelodysplastic Syndrome MDS 65 Renal Function 65 Elderly Patients 65 Sitagliptin 65 Newly Diagnosed Multiple Myeloma 65 Immunotherapeutic 65 Treated Patients 65 Chronic Hepatitis C 65 Adalimumab 65 Transdermal Patch 65 oral JAK1 65 Boceprevir 65 Hematopoietic Stem Cells 65 PKC inhibitor 65 Radiofrequency Ablation 65 Calcitonin 65 thalidomide Thalomid 65 Respiratory Virus 65 gefitinib Iressa 65 adrenoceptor 65 Clinical Relevance 65 CYP#A# substrate 65 somatostatin analogs 65 Sustained Release 65 antisense oligonucleotide 65 generation purine nucleoside 65 orally administered inhibitor 65 mecamylamine 65 Zoloft sertraline 65 abacavir Ziagen 65 Phospholipase A2 65 PI3 Kinase 65 Survival Benefit 65 vapreotide acetate 65 dual endothelin receptor antagonist 65 Contrast Agents 65 Anti VEGF 65 PDE4 65 TNF Tumor Necrosis Factor 65 downregulates 65 anti angiogenic agent 65 Temsirolimus 65 Newly Diagnosed 65 β2 65 CYP #D# 65 mGluR 65 Combo Therapy 65 targeting CD# 65 Drug Shows Promise 65 agonist compounds 65 Endothelin 65 HCl Injection 65 Tablet Formulation 65 Universal Flu Vaccine 65 Exemestane 65 administered subcutaneously 65 NDA Submission 65 PI3K Akt 65 Silodosin 65 selective agonist 65 Ecallantide 65 Nicotine Vaccine 65 FDA Approvals 65 BAL# [002] 65 monocyte chemotactic protein 65 insulin secretagogue 65 Roflumilast 65 Glufosfamide 65 Tigecycline 65 receptor subtype 65 Subtypes 65 Prospective Randomized 65 Anticancer Compound 65 Valsartan 65 murine monoclonal antibody 65 pDC 65 Therapeutic Efficacy 65 receptor antagonist 65 mitogenic 65 mediated inhibition 65 Adjunctive 65 Phase III Trials 65 HepG2 cells 65 Antiplatelet 65 vidofludimus 65 Glucocorticoids 65 Hepatocellular Carcinoma 65 pan HDAC inhibitor 65 generation antisense inhibitor 65 Severe Sepsis 65 MEK ERK 65 Rigel R# 65 Tanespimycin 64 Galantamine 64 Fracture Risk 64 Sipuleucel T 64 Cyclophosphamide 64 substrates inhibitors 64 Antipsychotic 64 piroxicam 64 Anti Angiogenic 64 Phase III Clinical Trials 64 Tacrolimus 64 ß2 64 First Patient Dosed 64 Zoledronic Acid 64 Calcineurin 64 Melphalan 64 FASLODEX 64 Solid Tumors 64 FDA Okays 64 Platelet Derived Growth 64 Posaconazole 64 TGF ß 64 Paraplatin ® 64 bile acid sequestrant 64 thyrotropin 64 Vascular Endothelial Growth 64 prostaglandin E 64 cytidine 64 Subtype 64 Shows Efficacy 64 IgG1 64 Dose Finding 64 Luminal 64 Subcutaneous 64 5 HT1A 64 Monoclonal 64 Tipranavir 64 Autoimmune Disease 64 aurora kinase 64 Randomized Double Blind 64 Esomeprazole 64 5 HT4 64 exendin 4 64 Transmembrane 64 MEVACOR 64 Glycoprotein 64 Septic Shock 64 Ofatumumab 64 Biolimus A9 64 Demonstrates Significant 64 Phosphatase 64 Gene Variants 64 NK1 64 Advanced Colorectal Cancer 64 CDDO Im 64 Synthetic Peptide 64 Trabectedin 64 EGFr 64 Apoptotic 64 Beta Amyloid 64 Beneficial Effects 64 insulin sensitizing 64 Angioedema 64 TNF α 64 thromboxane A2 64 Non Steroidal Anti Inflammatory 64 Eltrombopag 64 Pegylated Interferon 64 Omacetaxine 64 Epoetin Alfa 64 mGluR2 NAM 64 alkylating agent 64 selectively binds 64 tubulin polymerization 64 Lp PLA 2 64 P#Y# [002] 64 Fluconazole 64 tricyclic 64 Endothelial Cells 64 PPARγ 64 Polymorphisms 64 nimodipine 64 Improved Survival 64 pharmacokinetic interactions 64 Cognitive Impairment 64 TNFα 64 Cell Proliferation 64 Bronchodilator 64 alpha 2a 64 converting enzyme 64 Treatment Regimen 64 Treprostinil 64 T#I [002] 64 immune modulatory 64 Myelodysplastic Syndrome 64 Increased Mortality 64 Tyrosine Kinase 64 Carcinomas 64 R lenalidomide 64 HoFH 64 Chronic Myeloid Leukemia 64 alfa 2a 64 antifibrotic 64 IFN β 64 Interferon beta 1a 64 Novel Protein 64 LPA1 receptor 64 treat benign prostatic 64 Investigational Treatment 64 LPS induced 64 Darusentan 64 p# MAPK 64 Receptor Signaling 64 Technosphere ® 64 Higher Doses 64 partial agonist 64 Preclinical Evaluation 64 Oral Insulin 64 ACC2 64 Pharmacokinetics 64 somatostatin analogues 64 Lipid Levels 64 Bruton tyrosine kinase Btk 64 Pioglitazone 64 Romidepsin 64 ketoconazole 64 Restenosis 64 Excretion 64 venlafaxine Effexor 64 Leukocyte 64 VEGF receptor 64 adalimumab Humira 64 Salmeterol 64 Enlarged Prostate 64 #beta HSD1 64 Slow Progression 64 Postmenopausal Women 64 small molecule tyrosine 64 Antisense Oligonucleotides 64 Ozarelix 64 Integrase Inhibitor 64 Oritavancin 64 TO AVOID PREGNANCY WHILE 64 Bisphosphonate 64 Chronic Lymphocytic Leukemia 64 Intravascular 64 Chronic Sinusitis 64 Rotigotine 64 Thrombin 64 Glucagon Like Peptide 64 Initiates Clinical Trial 64 metastatic malignant 64 Erectile Dysfunction Drug 64 novel VDA molecule 64 cytochrome p# 64 Sugammadex 64 activate AMPK 64 Schizophrenia Treatment 64 endothelin receptor antagonists 64 Adenoviral 64 Allosteric 64 Leukemias 64 thrombocythemia 64 Celecoxib 64 Janus Kinase 64 adrenergic agonists 64 Xyfid TM 64 Submits NDA 64 Patients Treated 64 Coadministration 64 peroxisome proliferator activated 64 alpha GAL 64 Elagolix 64 HCV RNA polymerase 64 flavopiridol 64 Chronic Hepatitis B 64 Menopausal Symptoms 64 Vaprisol 64 Adenoma Prevention 64 CCR2 64 cytochrome P 64 Inhibit 64 Cancer Cells 64 Lymphoid 64 nicotinic acetylcholine receptor 64 Sandostatin R 64 ERK signaling 64 Randomized Phase II 64 Mesalamine 64 Reduced Risk 64 SAR# [002] 64 Insulins 64 Hepatic Encephalopathy 64 Cathepsin S 64 Demonstrates Potential 64 microglial activation 64 Naive Patients 64 Fluticasone 64 rhIL 7 64 panitumumab Vectibix 64 Resistant Hypertension 64 cannabinoid receptor 64 Relapsed Refractory 64 MGd 64 Superoxide 64 Multidrug 64 Imiquimod 64 Polymerase 64 angiogenesis inhibitor 64 PDE4 inhibitor 64 Hepatic 64 calcipotriene 64 Initiates Phase III 64 Lupus Nephritis 64 Modulating 64 Meta Analysis 64 mGluR2 64 lipoxygenase 64 IL #E 64 Ambrisentan 64 Secondary Hyperparathyroidism 64 SYN# 64 CGRP 64 Endovascular Treatment 64 Neuroprotection 64 Gefitinib 64 P#Y# [001] 64 sitaxsentan 64 inhibitor COX 64 deoxy 64 riociguat 64 serotonin receptor 64 hydroxocobalamin 64 related apoptosis inducing 64 Dupuytren Contracture 64 Follicular Lymphoma 64 Statin Therapy 64 elastase 64 Cancer Vaccines 64 Myocardial Ischemia 64 Gene Mutation 64 Gleevec resistant 64 Risk Stratification 64 1beta 64 Castration Resistant Prostate Cancer 64 BMS # 64 topical gel formulation 64 Cyclosporine 64 Hormone Receptor Positive 64 receptor modulator 64 Glucagon 64 Omalizumab 64 MET VEGFR2 64 Postmenopausal Osteoporosis 64 Fast Track Status 64 Human Monoclonal Antibody 64 orally dosed 64 Metastases 64 Lupus Drug 64 HIF 1a 64 nucleotide analog 64 prescribed proton pump 64 Budesonide 64 ergot derivatives 64 Rheumatoid Arthritis Patients 64 Liver Injury 64 androgen receptor AR 64 Intravitreal 64 Inhalation Solution 64 Saforis 64 Relapsing Remitting Multiple Sclerosis 64 Genotypes 64 irreversible inhibitor 64 HMG CoA reductase inhibitor 64 Interferon beta 1b 64 Oligonucleotides 64 NS5A 64 Bevirimat 64 proteasome inhibitors 64 Alkaline Phosphatase 64 annexin 63 Contraindications 63 somatostatin analogue 63 Abciximab 63 myeloproliferative diseases 63 Kuvan sapropterin dihydrochloride 63 Immunogenic 63 Angiotensin converting enzyme inhibitors 63 Ezetimibe 63 LHRH 63 Pharmacodynamic 63 ERK phosphorylation 63 Anti Inflammatory Drug 63 sphingosine 1 63 Oncolytic Reovirus 63 Hyperkalemia 63 Endothelial 63 Targeted Therapy 63 Teriflunomide 63 hepatotoxic 63 prostaglandin synthesis 63 serotonin reuptake 63 Demonstrates Statistically Significant 63 mGluRs 63 Anticancer Drug 63 ALN HPN 63 Randomized Clinical Trial 63 alpha1 proteinase inhibitor 63 secondary hyperparathyroidism 63 Ischemic 63 monocytes macrophages 63 Poster Discussion 63 receptor blockers 63 RNAi Therapeutic 63 Cell Lymphoma 63 Nymox NX 63 erlotinib Tarceva 63 Toremifene 63 Hematological 63 regulated kinase 63 Glycosylation 63 chronic idiopathic thrombocytopenic purpura 63 JAK1 63 SIRT2 63 norepinephrine reuptake inhibitor 63 Cellular Immunotherapy 63 selective kinase inhibitor 63 Clinical Efficacy 63 Lipoprotein 63 Neuropeptide Y 63 sulindac 63 Nucleotide 63 SGLT1 63 alpha#beta# integrin 63 adipogenic 63 CYT# potent vascular disrupting 63 Liver Toxicity 63 Aerosolized 63 Oral Anticoagulant 63 agonists antagonists 63 Linaclotide 63 AZILECT R 63 Sevelamer 63 azacytidine 63 Neurotransmitter 63 Shown Effective 63 Novel Compound 63 HT 1A 63 Peptide YY 63 Levels Linked 63 Vicriviroc 63 TH# [003] 63 MTHFR 63 plasminogen activator inhibitor 63 Prolactin 63 Cathepsin B 63 Trp p8 63 multikinase inhibitor 63 Tumor necrosis factor 63 topically administered 63 alpha blocker 63 Phospholipase 63 Omacetaxine mepesuccinate 63 interleukin IL 63 Irinotecan 63 Vidofludimus 63 Symadex 63 Potent Antiviral Activity 63 microtubule targeting 63 Capsules CII 63 Ocrelizumab 63 Oral Mucositis 63 selective inhibitor 63 Nitazoxanide 63 Renal Impairment 63 Azacitidine 63 vWF 63 angiotensin converting enzyme inhibitors 63 AnaSpec Introduces 63 p# mitogen activated 63 luteinizing hormone releasing 63 IAP inhibitor 63 Interferon alpha 63 Progressive Multifocal Leukoencephalopathy 63 Abatacept 63 Conjugated 63 Anti angiogenic 63 TNFalpha 63 5 HT2A receptor 63 small molecule activator 63 cell adhesion molecule 63 amifostine 63 NM# [003] 63 Commences Phase 63 Selective Inhibitor 63 TIMP 1 63 Topoisomerase 63 R roscovitine